Chung Chung, MD

Hospital Campus

Clinic/Unit

• Gamma Knife Center (Gamma Knife Referrals)
  Campus West Building (CWB)
  Google Maps & Directions
  750 East Adams Street
  Syracuse, NY 13210
  315 464-8400/8401
  
• University Radiation Oncology
  Upstate University Hospital - Downtown Campus
  Google Maps & Directions
  Rm. 222, 750 East Adams Street
  Syracuse, NY 13210
  315 464-5276
  
• Hill Radiation Oncology
  Hill Medical Center
  Google Maps & Directions
  Suite 101, 1000 East Genesee Street
  Syracuse, NY 13210
  315 476-3535
  

Education & Fellowships

• Residency: SUNY Health Science Center at Syracuse, 1974, Radiation Oncology
• MD: Yonsei University, Seoul, Korea, 1967

Specialties & Certification

• Radiation Oncology

Diseases & Conditions Treated

• Esophageal Cancer
• Laryngeal Cancer
• Nasal Cavity Cancer
• Oral Cancer
• Orbit Cancer

Treats

• Adults and Children

Treatments/Services

• Brachytherapy
• Gamma Knife Radiosurgery
• High Dose Rate (HDR) Afterloader Brachytherapy
• Image Guided Radiation Therapy (IGRT)
• Intensity Modulated Radiation Therapy (IMRT)
• Low Dose Rate Brachytherapy
• Radiation Therapy
• Stereotactic Body Radiation Therapy (SBRT)
• Stereotactic Guided Radiosurgery (SRS)

Associations/Memberships

• American College of Radiology (ACR)
• American Society of Clinical Oncology - ASCO
• Radiological Society of North America (RSNA)
• American Medical Association

Current Hospital Privileges

• Upstate University Hospital
• Crouse Hospital
• St. Joseph's Hospital Health Center
• VA Medical Center

Languages Spoken (Other Than English)

• Korean

Publications

Link to PubMed (Opens new window. Close the PubMed window to return to this page.)

Research Abstract

Treatment of Advanced Head and Neck Cancer with Altered Fractionation Radiotherapy in Combination with Chemotherapy. With S. Lemke, R. Young, R. Kellman, R. Kelley, S. Tatum, J. Bogart and J. Aronowitz

For advanced cancers of the head and neck, surgery in combination with irradiation has become the mainstay of treatment. However, survival results are still disappointing, and functional results may be undesirable. Efforts to improve the results of these treatments as well as to preserve the organs have led to an increasing role for chemotherapy. We have completed preliminary pilot studies of neoadjuvant chemotherapy with carboplatin, 5-fluorouracil and leucovorin, followed by altered fractionation radiotherapy with concurrent taxol. In altered fractionation radiotherapy, the second half of the treatments are given twice daily in an attempt to increase local tumor control. This protocol has special merits, with neoadjuvant chemotherapy, which may shrink the tumor, and may also have a role in preventing distant metastases, and altered fractionation radiotherapy, which probably is superior to standard fractionation, with concurrent chemotherapy, which may enhance the radiation effect.